Who
Christine Marie Utter
SVP, Chief Accounting Officer
Company insider
Files Form 4 as: SVP, Chief Accounting Officer, PTC Therapeutics.
In numbers
- Trades disclosed
- 188
- Buys
- 0
- Sells
- 44
- Bought
- $0
- Sold
- $12.9M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 2 Jun 2017
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code M | $506K19,686 at $25.69 | filing |
| 17 Jun 2026filed 22 Jun 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.5M19,686 at $75.56 | filing |
| 17 Jun 2026filed 22 Jun 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —19,686 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —19,686 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code M | $506K19,686 at $25.69 | filing |
| 17 Jun 2026filed 22 Jun 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.5M19,686 at $75.56 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $173K2,494 at $69.36 | filing |
| 18 Feb 2026filed 20 Feb 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $173K2,494 at $69.36 | filing |
| 8 Jan 2026filed 12 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $79K1,034 at $76.45 | filing |
| 8 Jan 2026filed 12 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $79K1,034 at $76.45 | filing |
| 7 Jan 2026filed 8 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $96K1,235 at $77.45 | filing |
| 7 Jan 2026filed 8 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $96K1,235 at $77.45 | filing |
| 6 Jan 2026filed 8 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $106K1,381 at $76.95 | filing |
| 6 Jan 2026filed 8 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $106K1,381 at $76.95 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code A | —13,250 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,125 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —33,125 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Code A | —13,250 at $0.00 | filing |
| 20 Feb 2025filed 21 Feb 2025 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $44K878 at $50.12 | filing |
| 19 Feb 2025filed 21 Feb 2025 | PTCT PTC TherapeuticsBiotechnology | SEC FORM 4 Sold | $44K879 at $50.10 | filing |
News
PTC Therapeutics (NASDAQ:PTCT) Director Michael Schmertzler Sells 2,500 Shares of Company StockPTCT · tickerreport.com · 16 Oct 2026PTC Therapeutics (NASDAQ:PTCT) Stock: Insider Mark Elliott Boulding Sells 1,638 SharesPTCT · themarketsdaily.com · 9 Oct 2026Insider Selling: PTC Therapeutics (NASDAQ:PTCT) VP Sells $27,909.60 in StockPTCT · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name Christine Marie Utter; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.